What Happened?
, -based Axonics Modulation Technologies Promoted Kari Keese as Chief Financial Officer
About the Company
Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable IPG licensed from the Alfred Mann Foundation. The Axonics Sacral Neuromodulation System is designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction.
About the Person
Kari Keese is Chief Financial Officer at Axonics Modulation Technologies. Previously, Kari held various senior HR leadership roles in the industry.
Info Source
News
Short Profile